1. 劉珍芳。炸油餵食對老鼠體內維生素 E 代謝的影響。國立台灣大學農業化學系博士論文。1993。2. 張廉筠。飲食炸油對小鼠腎臟抗氧化狀況與組織損傷之影響。嘉南藥理科技大學營養與保健科技研究所碩士論文。2009。3. 王正一。慢性潰瘍性結腸炎在台灣的發生概況。台灣發炎性腸道疾病病友會 http://www.ibdpg.tw/health.php。2009。
4. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G7–17.
5. Boismenu R and Chen Y. Insights from mouse models of colitis. J Leukoc Biol. 2000;67: 267–278.
6. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005 Jun; 288(6):G1328-38. Epub 2005 Jan 6.
7. Melgar S, Bjursell M, Gerdin AK, Svensson L, Micha?sson E, Bohlooly-Y M. Mice with experimental colitis show an altered metabolism with decreased metabolic rate. Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G165-72. Epub 2006 Jul 13.
8. Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin. 2007;28(9):1450-9.
9. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694-702.
10. White PJ. 1991. Methods for measuring changes in deep-fat frying oils. Food Technology 45:75.
11. 趙蓓敏。氧化炸油活化 PPAR之探討。國立台灣大學農業化學研究所博士論文。2002。12. Liao CH, Shaw HM, Chao PM. Impairment of glucose metabolism in mice induced by dietary oxidized frying oil is different from that induced by conjugated linoleic acid. Nutrition. 2008;24(7-8):744-52.
13. Chen YY, Liu JF, Chen CM, Chao PY, Chang TJ. A study of the antioxidative and antimutagenic effects of Houttuynia cordata Thunb. using an oxidized frying oil-fed model. J Nutr Sci Vitaminol (Tokyo). 2003;49(5):327-333.
14. Izaki Y, Yoshikawa S, Uchiyama M. Effect of ingestion of thermally oxidized frying oil on peroxidative criteria in rats. Lipids. 1984;19(5):324-331.
15. Liu JF, Huang CJ. Tissue alpha-tocopherol retention in male rats is compromised by feeding diets containing oxidized frying oil. J Nutr. 1995; 125(12):3071-80.
16. Liu JF, Huang CJ. Dietary oxidized frying oil enhances tissue alpha-tocopherol depletion and radioisotope tracer excretion in vitamin E-deficient rats. HJ Nutr.H 1996 Sep;126(9):2227-35.
17. Totani N, Ojiri Y. Mild ingestion of used frying oil damages hepatic and renal cells in Wistar rats. J Oleo Sci. 2007;56(5):261-267.
18. 鄭瑋宜。飲食炸油對鈉鉀平衡及前列腺素合成之影響。國立台灣大學農業化學研究所碩士論文。2001。19. 湯雅理。飲食炸油與腎臟前列腺素 E2合成。國立台灣大學農業化學系博士論文。2000。20. Huang CJ. Effects of deteriorated frying oil and dietary protein levels on liver microsomal enzymes in rats. JAOCS. 1988;65(11):1796-1803.
21. Sulzle A, Hirche F, Eder K. Thermally oxidized dietary fat upregulates the expression of target genes of PPAR alpha in rat liver. J Nutr. 2004; 134(6) : 1375-1383.
22. Totani N, Ojiri Y. Thermal deterioration of oil and frying foodstuffs. J Oleo Sci. 2007;56(10):543-551.
23. 黃惠玲。膳食油脂與 clofibrate 改變大鼠鐵代謝及其相關蛋白質表現.國立台灣大學農業化學研究所博士論文。2001。24. Narasimhamurthy K, Raina PL. Long term feeding effects of heated and fried oils on lipids and lipoproteins in rats. Mol Cell Biochem. 1999; 195(1-2) : 143-153.
25. Braun S, Hanselmann C, Gassmann MG, et al. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol. 2002 Aug; 22(15):5492-5505.
26. Li W, Kong AN. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 2009;48 (2): 91–104.
27. Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009;284 (20): 13291–13295.
28. Surh YJ, Na HK. NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr. 2008 Feb;2(4):313-317.
29. Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13 (1): 76–86.
30. Jaiswal AK. Antioxidant response element. Biochem Pharmacol. 1994 Aug 3;48(3):439-444.
31. Zhu H, Zhang L, Amin AR, Li Y. Coordinated upregulation of a series of endogenous antioxidants and phase 2 enzymes as a novel strategy for protecting renal tubular cells from oxidative and electrophilic stress. Exp Biol Med. (Maywood). 2008;233(6):753-765.
32. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236(2): 313-322.
33. Li W, Khor TO, Xu C, et al. Activation of Nrf2-antioxidant signaling attenuates NF-kappa B-inflammatory response and elicits apoptosis. Biochem Pharmacol. 2008;76(11):1485-1489.
34. Osburn WO, Karim B, Dolan PM, et al. Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer. 2007;121(9):1883-1891.
35. Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 2006;66 (24):11580-11584.
36. Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12731-6.
37. Enomoto A, Itoh K, Nagayoshi E, et al. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci. 2001 Jan;59(1):169-177.
38. McMahon M, Itoh K, Yamamoto M, et al. The Cap''n''Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 2001; 61(8): 3299-3307.
39. Ramos-Gomez M, Kwak MK, Dolan PM, et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA. 2001; 98(6): 3410-3415.
40. HSzeto FLH, HSun JH, HKong J,H et al. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts. HJ Steroid Biochem Mol Biol.H 2007 Mar;103(3-5):563-6.
41. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25 (51): 6680–6684.
42. Nelson DE, Ihekwaba AE, Elliott M, et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004;306 (5696): 704–708.
43. Brasier AR. The NF-κB regulatory network. Cardiovasc. Toxicol. 2006; 6 (2): 111–130.
44. Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 2007; 8 (1): 49–62.
45. Yanai A, Maeda S, Shibata W, et al. Activation of IkappaB kinase and NF-kappaB is essential for Helicobacter pylori-induced chronic gastritis in Mongolian gerbils. Infect Immun. 2008 Feb;76(2):781-7. Epub 2007 Dec 10.
46. Janssen-Heininger YM, Poynter ME, Aesif SW, et al. Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proc Am Thorac Soc. 2009 May 1;6(3):249-55.
47. 謝文亮、陳瑞瑩、黃莉蓉。NF-B 訊息傳遞抑制劑之治療潛力。台灣醫學。2003;7(1)。
48. Albensi BC, Mattson MP. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse. 2000; 35 (2): 151–159.
49. 葉獻詞、吳正祥。蛋白?§珧囧? 2、NF-B 在潰瘍性結腸炎腸黏膜的表達及其與肥大細胞相關性研究。胃腸病學和肝病學雜誌。2009 Feb;138-141。
50. 劉元山、陳劍群、朱炳喜。細胞因數表達與 NF-κB 活化在潰瘍性結腸炎發病中的意義。徐州醫學院學報。2009;553-556。
51. Marrero JA, Matkowskyj KA, Yung K, Hecht G, Benya RV. Dextran sulphate sodium-induced murine colitis activates NF-kappaB and increases galanin-1 receptor expression. Am J Physiol Gastrointest Liver Physiol. 2000; 278:G797-804.
52. Rojas-Cartagena C, Flores I, Appleyard CB. Role of tumor necrosis factor receptors in an animal model of acute colitis. Cytokine. 2005;32: 85–93.
53. Kinoshita K, Hori M, Fujisawa M, et al. Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice. Neurogastroenterol Motil. 2006;18(7): 578–588.
54. Kurtovic J, Segal I. Recent advances in biological therapy for inflammatory bowel disease. Trop Gastroenterol. 2004;25(1): 9–14.
55. Packer L, Weber SU, Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr. 2001 Feb;131(2):369S-73S.
56. National Institute of Health. Vitamin E Fact Sheet. 2009. http://ods.od.nih.gov/factsheets/VitaminE.asp.
57. Herrera; Barbas, C. Vitamin E: action, metabolism and perspectives. Journal of physiology and biochemistry.2001; 57 (2): 43–56.
58. Traber; Atkinson, J. Vitamin E, antioxidant and nothing more. Free radical biology & Medicine. 2007; 43 (1): 4–15.
59. Brigelius-Flohe, Regina; Traber, M. Vitamin E: function and metabolism. The FASEB Journal. 1999; 13 (10): 1145. http://www.fasebj.org/cgi/content/short/13/10/1145.
60. Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. HAm J Gastroenterol.H 1989 Jul;84(7):744-8.
61. Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J. Pediatr. Gastroenterol. Nutr. 1998; 26: 129–135.
62. Buffinton GD and Doe WF. Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic. Biol. Med. 1995; 19: 911–918.
63. Suzuki YJ and Packer L. Inhibition of NF-kappaB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 1993; 193(1): 277–283.
64. Suzuki YJ and Packer L. Inhibition of NF-kappa B DNA binding activity by -tocopheryl succinate. Biochem. Mol. Biol. Int. 1993; 31(4): 693–700.
65. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol. 1996; 157: 1630-1637
66. Naraghi M, Deroee AF, Ebrahimkhani M, Kiani S, Dehpour A. Nitric oxide: a new concept in chronic sinusitis pathogenesis. Am J Otolaryngol. 2007; 28(5): 334-337
67. Sato K, Kanazawa A, Ota N, Nakamura T, Fujimoto K. Dietary supplementation of catechins and -tocopherol accelerate healing of trinitrobenzene sulfonic acid-induced ulcerative colitis. J. Nutr. Sci. Vitaminol. 1998; 44: 769–778.
68. Ademoglu E, Erbil Y, Tam B, et al. Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig Dis Sci. 2004; 49(1): 102-108
69. 陳惠民。植物中的鑽石-高經濟價值的辣木。商周出版。2005。
70. Muyibi SA, Evison LM. Moringa oleifera seeds for softening hardwater. Wat. Res. 1994;29:1099-1105.
71. 陳澤琪。奇蹟之樹-辣木。旗林出版社,台北。2003。
72. 康淑敏。辣木組成分與生理活性之探討。國立台灣海洋大學食品科學系碩士論文。2006。73. Tarwadi K, Agte V. Potential of commonly consumed green leafy vegetables for their antioxidant capacity and its linkage with the micronutrient profile. Int J Food Sci Nutr. 2003;54(6):417-425.
74. Ross IA. Medicinal Plant of the World: Chemical Constituents, Traditional and Modern Medicinal Uses. Humana Press, Totowa, New Jersey. 1999; 231–239.
75. 段瓊芬、李迅、陳思多、李馬一、安鑫南。辣木營養價值的開發利用。安徽農業科學。2008;36:12670-72。
76. Crawford JM. Robbin’s Pathologic Basis of Disease. New Delhi, India, Saunders. 2003;787-802.
77. V.C. Devaraj, Mohammed Asad, and Satya Prasad. Effect of leaves and fruits of moringa oleifera on gastric and duodenal ulcers. Pharm Biol.2007; 45(4) :332–338
78. Ezeamuzle IC, Ambadederomo AW, Shode FO, Ekwebelem SC. Anti-inflammatory effects of Moringa oleifera root extract. Int J Pharmacogn. 1996;34: 207–212.
79. Limaye DA, Nimbkar AY, Jain R, Ahmad M. Cardiovascular effects of the aqueous extract of Moringa pterygosperma. Phytother Res. 1995;9:37-40.
80. 李宜靜。尿中 -CEHC 對飲食維生素 E 攝取量之反應評估。國立
台灣大學微生物與生化學研究所碩士論文。2004。
81. Tatum VL, Changchit C, Chow CK. Measurement of malondialdehyde by high performance liquid chromatography with fluorescence detection. Lipids. 1990;25:226-229
82. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and non protein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. 1968;25:192-205
83. Omaye ST, Turubull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissue, and fluids. Method Enzymol. 1979;62:3-11.
84. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126.
85. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-169.
86. 陳慧琳。大蒜精油及其活性成分—二烯丙基硫化物、二烯丙基二硫化物對大白鼠肝癌形成、血脂質、紅血球GSH及GSH相關代謝酵素活性之影響。中山醫學院營養科學研究所碩士論文。1996。
87. Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol. 1984;105:93-105.
88. Akcan A, Muhtaroglu S, Akgun H, et al. Ameliorative effects of bombesin and neurotensin on trinitrobenzene sulphonic acid-induced colitis, oxidative damage and apoptosis in rats. World J Gastroenterol. 2008; 14(8): 1222-30.
89. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem.1951;193(1):265-275.
90. 莊榮輝。水稻蔗糖合成?﹞妞膍s。國立台灣大學農業化學研究所博士論文。1985。
91. 黃曉婷。炸油對大鼠腹部脂質堆積、脂肪細胞分化及胰島素敏感性研究。中國醫藥大學營養所碩士論文。2005。92. 牟宗怡。炸油與維生素E 對卵蛋白致敏 BALB/c 鼠過敏免疫反應之影響。國立台灣大學農業化學研究所碩士論文。1998。
93. 陳美伶。不同飽和程度油脂經油炸處理對老鼠小腸及肝臟維生素 A、維生素 E 及微粒體酵素系統 Cytochrome P-450 的影響。國立台灣大學農業化學研究所碩士論文。1996。94. Chao PM, Yang MF, Tseng YN, Chang KM, Lu KS, Huang CJ. Peroxisome proliferation in liver of rats fed oxidized frying oil. J Nutr Sci Vitaminol (Tokyo). 2005;51(5):361-368.
95. 戚祖沅。黃豆油含量與炸油攝取對 NZB/W F1 自體免疫鼠病情發展之影響探討。台大農化所碩士論文。1996。96. Asleh R, Levy AP. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc Health Risk Manag. 2005; 1 (1): 19–28.
97. Papp M, Lakatos PL, Palatka K, et al. Haptoglobin polymorphisms are associated with Crohn''s disease, disease behavior, and extraintestinal manifestations in Hungarian patients. Dig. Dis. Sci. 2007; 52 (5): 1279–84.
98. Costa-Mallen P, Checkoway H, Zabeti A, et al. The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson''s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008; 147B (2): 216–22.
99. Balkwill F. Tumour necrosis factor and cancer. Nature Reviews Cancer. 2009 May; 9(5):361-71. Epub 2009 Apr 3.
100. Ishiguro Y. Mucosal proinflammarory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol. 1999;34(1):66-74.
101. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991 Aug;32(8):913-7.
102. Kliewer SA. The nuclear pregnane X receptor regulates xenobiotic detoxification. J Nutr. 2003;133(7 Suppl):2444S-2447S.
103. 黃玟綺。氧化炸油對大鼠維生素 E 代謝相關蛋白質與基因表現之影響。嘉南藥理科技大學營養與保健科技研究所碩士論文。2008。104. Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys. 1983 Feb 15;221(1):281-90.
105. 方素琦。餵食高量維生素E對於 MRL/lpr 自體免疫鼠病情影響之探討。台大農化所碩士論文。1998。
106. Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:179-89.
107. Logan RF. Inflammatory bowel disease incidence: up, down or unchanged? Gut. 1998;42:309-11.
108. Ringseis R, Piwek N, Eder K. Oxidized fat induces oxidative stress but has no effect on NF-kappaB-mediated proinflammatory gene transcription in porcine intestinal epithelial cells. Inflamm Res. 2007;56(3):118-125.